| Price | 1,348.00p on 18-07-2025 at 18:40:05 |
|---|---|
| Change | -65.00p -4.6% |
| Buy | 1,349.00p |
| Sell | 1,348.50p |
| Buy / Sell GSK Shares | |
| Last Trade: | Unknown 963.00 at 1,348.00p |
| Day's Volume: | 17,185,023 |
| Last Close: | 1,348.00p |
| Open: | 1,320.00p |
| ISIN: | GB00BN7SWP63 |
| Day's Range | 1,315.00p - 1,361.50p |
| 52wk Range: | 1,242.50p - 1,678.00p |
| Market Capitalisation: | £54.46b |
| VWAP: | 1,337.94945p |
| Shares in Issue: | 4.04b |
Glaxosmithkline (GSK) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 963 | 1,348.00p | OTC Trade |
16:37:53 - 18-Jul-25 |
| Unknown* | 73 | 1,348.00p | OTC Trade |
16:37:53 - 18-Jul-25 |
| Unknown* | 87 | 1,348.00p | OTC Trade |
16:37:53 - 18-Jul-25 |
| Sell* | 784 | 1,348.00p | Automatic Execution |
16:35:59 - 18-Jul-25 |
| Sell* | 5,160 | 1,348.00p | Automatic Execution |
16:35:59 - 18-Jul-25 |
| Sell* | 900 | 1,348.00p | Automatic Execution |
16:35:59 - 18-Jul-25 |
| Sell* | 9,236 | 1,348.00p | Automatic Execution |
16:35:59 - 18-Jul-25 |
| Sell* | 5,160 | 1,348.00p | Automatic Execution |
16:35:23 - 18-Jul-25 |
| Sell* | 8,292 | 1,348.00p | Automatic Execution |
16:35:14 - 18-Jul-25 |
| Buy* | 486 | 1,348.836p | SI Trade |
16:29:58 - 18-Jul-25 |
Glaxosmithkline (GSK) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 18th Jul 2025 3:30 pm | RNS | Director/PDMR Shareholding |
| 18th Jul 2025 7:00 am | RNS | Transaction in Own Shares |
| 18th Jul 2025 7:00 am | RNS | Blenrep US ODAC outcome |
| 17th Jul 2025 7:00 am | RNS | GSK’s Shingrix Fully Liquid FDA approval |
| 17th Jul 2025 7:00 am | RNS | Transaction in Own Shares |
| 16th Jul 2025 7:00 am | RNS | Transaction in Own Shares |
| 15th Jul 2025 3:30 pm | RNS | Director/PDMR Shareholding |
| 15th Jul 2025 7:00 am | RNS | Transaction in Own Shares |
| 14th Jul 2025 3:30 pm | RNS | Director/PDMR Shareholding |
| 14th Jul 2025 7:00 am | RNS | GSK submits Arexvy for adults 18-49 AIR to FDA |
